1. Barbeau, A., Inoue, N., Tsukada, Y., and Butterworth, R.F., 1975, The neuropharmacology of taurine, Life Sci., 17: 669.
2. Ben-Ari, Y., 1985, Limbic seizure and brain damage produced by kainic acid; mechanisms and relevance to human temporal lobe epilepsy, Neuroscience, 14: 375.
3. Bonhaus, D.W., and Huxtable, R.J., 1984, Seizure-susceptibility and decreased taurine transport in the genetically epileptic rat, Neurochem. Int., 6: 365.
4. Bonhaus, D.W., Pasantes-Morales, H., and Huxtable, R.J., 1985, Actions of guanidinoethane sulfonate on taurine concentration, retinal morphology and seizure threshold in the neonatal rat, Neurochem. Int., 7: 263.
5. Coutinho-Netto, J., Abdul-Ghani, A.S., Collins, J.F., and Bradford, H.F., 1981, Is glutamate a trigger factor in epileptic hyperactivity?, Epilepsia, 21: 289.